Plain-English translation of NCT06224530 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Researchers are investigating whether , a medication already used to treat seizures, can affect brain function and chemistry in people who are at risk for developing psychosis. The study uses brain imaging scans to measure how the medication changes brain activity and how people perform on cognitive tasks. This is a small, carefully controlled research study to understand whether this medication might help people in the early stages of psychosis risk.
Some people show early warning signs of psychosis, like unusual thoughts, but haven't developed full psychosis yet. Researchers have noticed that certain areas of their brains (the hippocampus) work differently than in healthy people. This trial is exploring whether this medication might reduce that abnormal brain activity and potentially help prevent psychosis from developing further.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the research clinic three times over a few weeks. At your first visit, researchers will ask you questions and do some basic health checks (about 2 hours). Then you'll have two separate scanning visits where you'll receive either the medication or a placebo (a fake pill with no active ingredient) โ one at each visit, in random order. During each scan visit, you'll undergo brain imaging and complete some thinking and memory tasks. You won't know which visit you received the real medication and which the placebo until after the study ends.
AI-generated summary from trial data ยท Aug 11, 2026 ยท Not medical advice
United Kingdom